Champions Oncology (CSBR)
(Delayed Data from NSDQ)
$4.85 USD
-0.07 (-1.42%)
Updated Apr 30, 2024 09:30 AM ET
After-Market: $4.93 +0.08 (1.65%) 7:06 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.85 USD
-0.07 (-1.42%)
Updated Apr 30, 2024 09:30 AM ET
After-Market: $4.93 +0.08 (1.65%) 7:06 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
When Does Market Timing Actually Work? - March 16, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Timing the Market, Is it Possible? - February 26, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
When Does Market Timing Actually Work? - February 05, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
How to Time the Markets Like an Investing Pro - January 17, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Market Timing Secrets No One Talks About - December 24, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Simple Market Timing Strategies That Work - December 04, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Truth About Market Timing - November 14, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Truth About Market Timing - October 24, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
When Does Market Timing Actually Work? - October 03, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Truth About Market Timing - September 13, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Yes, You Can Time the Market. Find out How - August 26, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Simple Market Timing Strategies That Work - August 05, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Moving Average Crossover Alert: Champions Oncology
by Zacks Equity Research
Champions Oncology, Inc. (CSBR) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
New Strong Sell Stocks for April 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for April 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for March 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for March 25th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Champions Oncology (CSBR) Q3 Earnings: What's in Store?
by Zacks Equity Research
During Champions Oncology's (CSBR) third-quarter fiscal 2019 conference call, investor focus will be on the company's progress with its Ex Vivo platform and services.
Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away?
by Zacks Equity Research
Champions Oncology (CSBR) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Champions Oncology (CSBR) closed at $10.39, marking a +0.39% move from the previous day.
Champions Oncology (CSBR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Champions Oncology (CSBR) closed the most recent trading day at $12.41, moving -1.43% from the previous trading session.
Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Champions Oncology (CSBR) closed at $13.43 in the latest trading session, marking a +1.13% move from the prior day.
Champions Oncology Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Champions Oncology has been struggling lately, but the selling pressure may be coming to an end soon.
Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CSBR) Outperforming Other Medical Stocks This Year?
Champions Oncology (CSBR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Champions Oncology (CSBR) closed at $12.21 in the latest trading session, marking a +0.58% move from the prior day.